These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30129678)

  • 1. FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.
    Toeda Y; Kasamatsu A; Koike K; Endo-Sakamoto Y; Fushimi K; Kasama H; Yamano Y; Shiiba M; Tanzawa H; Uzawa K
    Mol Carcinog; 2018 Dec; 57(12):1690-1697. PubMed ID: 30129678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
    Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A2b receptor promotes progression of human oral cancer.
    Kasama H; Sakamoto Y; Kasamatsu A; Okamoto A; Koyama T; Minakawa Y; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    BMC Cancer; 2015 Jul; 15():563. PubMed ID: 26228921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
    Koide N; Kasamatsu A; Endo-Sakamoto Y; Ishida S; Shimizu T; Kimura Y; Miyamoto I; Yoshimura S; Shiiba M; Tanzawa H; Uzawa K
    Sci Rep; 2017 Feb; 7():43379. PubMed ID: 28230172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cavin-2 in oral cancer: A potential predictor for tumor progression.
    Unozawa M; Kasamatsu A; Higo M; Fukumoto C; Koyama T; Sakazume T; Nakashima D; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    Mol Carcinog; 2016 Jun; 55(6):1037-47. PubMed ID: 26086332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
    Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
    Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-gated sodium channel Nav1.5 promotes proliferation, migration and invasion of oral squamous cell carcinoma.
    Zhang J; Mao W; Dai Y; Qian C; Dong Y; Chen Z; Meng L; Jiang Z; Huang T; Hu J; Luo P; Korner H; Jiang Y; Ying S
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):562-570. PubMed ID: 31139826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
    Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
    Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
    Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
    Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
    Sasabe E; Tomomura A; Yamamoto T
    J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma.
    Hiroshima K; Shiiba M; Oka N; Hayashi F; Ishida S; Fukushima R; Koike K; Iyoda M; Nakashima D; Tanzawa H; Uzawa K
    Exp Cell Res; 2019 Nov; 384(2):111622. PubMed ID: 31518558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
    Dai J; Wei W
    Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
    Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas.
    Hiraishi Y; Wada T; Nakatani K; Negoro K; Fujita S
    Pathol Oncol Res; 2006; 12(2):87-91. PubMed ID: 16799709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD.
    Ge WL; Xu JF; Hu J
    Cell Physiol Biochem; 2016; 38(3):1209-17. PubMed ID: 26982322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
    Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
    Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
    Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
    Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.